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Podoplanin is a transmembrane glycoprotein that is upregulated in cancer and was reported to 
induce an epithelial-mesenchymal transition (EMT) in MDCK cells. The promotion of EMT 
was dependent on podoplanin binding to ERM (ezrin, radixin, moesin) proteins through its 
cytoplasmic (CT) domain, which led to RhoA-associated kinase (ROCK)-dependent ERM 
phosphorylation. Using detergent-resistant membrane (DRM) assays, as well as 
transmembrane (TM) interactions and ganglioside GM1 binding, we present evidence 
supporting the localization of podoplanin in raft platforms important for cell signalling. 
Podoplanin mutant constructs harbouring a heterologous TM region or lacking the CT tail 
were unable to associate with DRMs, stimulate ERM phosphorylation and promote EMT or 
cell migration. Similar effects were observed upon disruption of a GXXXG motif within the 
TM domain, which is involved in podoplanin self-assembly. In contrast, deletion of the 
extracellular (EC) domain did not affect podoplanin DRM association. Together, these data 
suggest that both the CT and TM domains are required for podoplanin localization in raft 
platforms, and that this association appears to be necessary for podoplanin-mediated EMT 
and cell migration. 
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kinase; TM, Transmembrane. 
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1. Introduction 
 
Podoplanin (PDPN), also called PA2.26 antigen, Aggrus, and T1, is a small 
membrane mucin-like type I glycoprotein expressed in mesothelia, osteoblasts, osteocytes, 
certain types of neurons, and several epithelia (Wicki and Christofori, 2007). It is also 
expressed in the lymphatic but not blood vessel endothelium, making podoplanin a useful 
immunohistochemical marker for lymphangiogenesis analysis (Ordonez, 2006). Studies with 
podoplanin-deficient mice have revealed it plays an important role for this glycoprotein in the 
morphogenesis of the lung (Ramirez et al., 2003), the formation of the lymphatic vasculature 
(Schacht et al., 2003) and cardiac development (Mahtab et al., 2008). Nevertheless, the 
precise biological function of podoplanin in normal tissues remains to be elucidated.  
Podoplanin is upregulated in a variety of cancers, and has been recently identified as a 
candidate cancer stem cell marker in squamous cell carcinomas (Atsumi et al., 2008). The 
general consensus about the role of podoplanin in cancer is that it promotes tumor cell 
migration, invasion and metastasis (Wicki and Christofori, 2007). 
The human podoplanin precursor polypeptide is 162 amino acids long. It is composed 
of an O-glycosylated EC domain followed by a hydrophobic TM segment and a CT tail of 
only nine amino acids (Martin-Villar et al., 2005). The EC region contains three repeats 
(PLAG domains) that have been shown to induce tumor-platelet aggregate formation and 
facilitate pulmonary metastasis (Kunita et al., 2007). We have shown that in premalignant 
keratinocytes and MDCK cells podoplanin induces an EMT that is associated with increased 
migration/invasion and lymph node metastasis (Scholl et al., 1999; Scholl et al., 2000; 
Martin-Villar et al., 2005; Martín-Villar et al., 2006). Podoplanin binds ezrin/moesin 
members of the ERM protein family through basic residues of its CT domain linking it to the 
actin cytoskeleton. This interaction is crucial for podoplanin-mediated activation of the small 
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GTPase RhoA and its associated kinase ROCK, thereby promoting an EMT (Martín-Villar et 
al., 2006). On the other hand, Wicki and coworkers (2006) reported that podoplanin is able to 
stimulate collective tumor cell migration/invasion in the absence of EMT by inducing a 
rearrangement of the actin cytoskeleton. These studies point to a crucial role of the EC and 
CT domains in podoplanin-induced cell adhesion and motility, respectively.  
Recently, Barth and colleagues (2010) have shown that podoplanin/T1 is associated 
with lipid raft micro domains in microvillar protrusions of lung alveolar epithelial cells. Raft 
constituents are normally present in the detergent-resistant membrane (DRM) fraction after 
non-ionic detergent solubilization at 4ºC. They are dynamic nanoscale assemblies of 
sphingolipids, cholesterol and proteins that can be stabilized into larger platforms and are 
involved in viral infection, membrane trafficking and signal transduction (Simons and Gerl, 
2010). In the present work, we have analyzed the involvement of the TM domain of 
podoplanin on its localization in DRMs and in the promotion of EMT.  
 
2. Materials and methods 
 
2.1. Constructs 
 
Constructs for enhanced green fluorescent protein (eGFP) fusion proteins of wild-type 
podoplanin (PDPN-WT), PDPN-∆CT and PDPN-∆EC have been described elsewhere 
(Martín-Villar et al., 2006). Constructs for TM chimeric and GXXXG mutants are described 
in detail in the Supplementary material section, including the oligonucleotides used for their 
amplification (Table S1). All PCR-derived constructs were confirmed by sequencing. 
 
2.2. Cell culture conditions and cDNA transfections 
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We used in this study MDCK type II cells, which do not express podoplanin (Zimmer 
et al., 1997; Zimmer et al., 1999; Martín-Villar et al., 2006). Cell culture conditions and 
plasmid transfections were as previously described (Martin-Villar et al., 2005). MDCK cell 
transfectants were selected with 0.5 mg/ml G418 (Promega Biotech Ibérica) for 2 weeks, and 
individual clones expressing podoplanin selected by sorting and flow cytometry. All 
experiments were performed with at least two different clones for each construct, yielding 
similar results. 
 
2.3. Detergent insolubility and OptiPrep
TM
 density gradient assays 
 
Triton X-100 insolubility assays were performed as described (Neame and Isacke, 
1992), with slight modifications. Briefly, confluent cell monolayers were washed twice in 
cold Tris-saline buffer (15 mM Tris-HCl, pH 7.5, 120 mM NaCl), scraped in 400 l of cold 
extraction buffer (5 mM Tris-HCl, pH 7.5, 1 mM CaCl2, 1 mM MgCl2, 150 mM NaCl, 0.2% 
Triton X-100, plus protease inhibitors), and incubated on ice for 10 min. Lysates were 
centrifuged at 18 000×g at 4ºC for 15 min to separate Triton-insoluble material. The 
supernatant was designed as the soluble fraction.  
For flotation experiments in OptiPrep
TM
 density gradients, cells were washed in cold 
PBS, lysed in TNE buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% 
Triton X-100, plus protease inhibitors) and incubated on ice for 20 min, as described by 
Gomez-Mouton et al. (2001). Cells were then scraped and passed several times through a 25-
gauge needle. Samples were brought to 35% (v/v) with cold OptiPrep
TM
 (Sigma-Aldrich) in 
TNE buffer (0.5 ml final volume), transferred into SW60 centrifuge tubes, overlaid with 3.5 
ml of 30% OptiPrep
TM
 in TNE buffer and 200 l of TNE buffer, and centrifuged for 4 h at 
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170 000×g at 4ºC. Eight 0.5 ml fractions were collected from the top of the gradient. The 
presence of podoplanin and raft markers in the fractions was analyzed by Western blotting. 
Density gradients for mutant podoplanin proteins were run in parallel to wild type podoplanin 
as a control. 
For cholesterol depletion, cells were washed in PBS and incubated with 20 mM methyl-
-cyclodextrin (CD, Sigma-Aldrich) in serum-free medium at 37ºC for 30 min. After 
incubation, CD was washed with serum-free medium containing 0.01 % BSA. In these 
conditions, ~90% of cholesterol is removed from MDCK cells (Francis et al., 1999). 
 
2.4. Western blot analysis  
 
Total cell lysates and Western blot analysis were performed as previously described 
(Martín-Villar et al., 2006). To detect podoplanin, an antibody raised against the peptide 37-
51 (P37-51) of the EC domain was used, and its specificity was verified by preincubating with 
an excess of this peptide (Martin-Villar et al., 2005). For podoplanin detection in OptiPrep
TM
 
density gradients, the commercial mAb NZ-1 (Acris antibodies) was used. Expression of 
CD44 was analyzed under non-reducing conditions with the rat mAb IM7, kindly provided by 
Helen Yarwood (The Institute for Cancer research, London, UK). Antibodies for phospho-
ERM and caveolin-1 (Cav-1) were from Cell Signaling Technology and BD Biosciences, 
respectively. Antibodies for ezrin (3C12), eGFP and -tubulin (DM1A) were from Sigma-
Aldrich, and mAbs for N-cadherin and CK8 were from Zymed Laboratories. The mAb 
ECCD-2 was used for E-cadherin detection. Appropriate horseradish-peroxidase-conjugated 
secondary antibodies were used.  
 
2.5. Bead assay 
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Five m in diameter polystyrene beads (Duke Scientific Corporation) were coated 
with 10 g/ml of cholera toxin B-subunit (CT-B) conjugated with Alexa Fluor-594 
(Calbiochem) or a polyclonal antibody (sc-9099, Santa Cruz Biotechnology) directed against 
the EC domain of the transferrin receptor, as described by del Pozo et al. (2004). Cells seeded 
on coverslips were washed with serum-free culture medium and incubated with coated beads 
(cell to bead ratio of 1:10) at 37ºC for 15 min. Cells were then washed three times with PBS 
to remove excess beads, and fixed/processed for immunofluorescence analysis. 
 
2.6. Fluorescence and confocal microscopy analysis 
 
Immunofluorescence detection of proteins was performed in cells fixed with 3.7% 
formaldehyde in PBS and permeabilized with 0.05% Triton X-100. For E-cadherin and CD44 
staining, the mAbs ECCD-2 and HP2/9 (a generous gift of F. Sánchez-Madrid, Hospital 
Universitario La Princesa, UAM), respectively, were used. Secondary antibodies were Alexa 
Fluor 594-labeled anti-rabbit or anti-mouse IgGs (Molecular Probes). Phalloidin coupled to 
Alexa Fluor 594 was used for F-actin staining. Nuclei were stained with a 1 g/ml solution of 
4’,6-diamino-2-phenilindole (DAPI; Sigma-Aldrich). In vivo podoplanin pre-embedding 
staining was performed as previously described (Martín-Villar et al., 2006). Confocal laser-
scanning microscopy was performed in a TCS-SP2 microscope (Leica Microsystems). Images 
were taken using a 63x (NA1.32) oil-immersion objective and assembled using the Leica 
Confocal Software 2.0 or Adobe® Photoshop® CS2.  
 
2.7. Cell migration assays and time-lapse microscopy 
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Wound healing assays were performed as described previously (Scholl et al., 1999). 
Images of the wounds were taken at 0 and 12 h after wounding, and quantification of 
migrated cells was done by measuring the number of pixels in the wounded area using 
Adobe® Photoshop®. For Transwell assays, cells were seeded (5x10
3
 cells/well) in DMEM 
containing 0.1% FBS and allowed to transmigrate for 6 h at 37ºC using 5% FBS as a 
chemoattractant. Cells on the upper side of the Transwell were then removed and those on the 
underside were fixed and stained with DAPI. Cell migration was quantified by counting the 
number of cells that migrated through the inserts. Four different fields per well were counted 
using an Axiophot fluorescence microscope (Carl Zeiss). 
Random migration analysis was performed with time-lapse fluorescence microscopy. 
Cells grown at low confluence were maintained at 37ºC in a 5% CO2 atmosphere. Images 
were taken every 5 min for 15 h with a Leica DMI6000B inverted fluorescence microscope 
(Leyca Microsystems) using a 10x objective. Cells entering or exiting the field, and those that 
divided during the time-lapse recording were excluded from the analysis. Images were 
processed, assembled into movies, and analyzed with Imaris 6.4.2 software. The following 
migration parameters were calculated: mean speed = total path length / time; displacement = 
distance between the starting and ending points of cell path; directionality = displacement / 
total path length.  
 
2.8. TOXLUC assay 
 
PDPN constructs, as well as the M1 TM segment of the human epithelial sodium 
channel  subunit (ENAC) from pKB52 (Kashlan et al., 2006), cloned in the TOXCAT vector 
pML27 (Lis and Blumenthal, 2006) were engineered to substitute the CAT gene for the 
luciferase gene (see supplementary material). Both plasmids were kindly provided by K. 
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Blumenthal (State University of New York, Buffalo, NY 14214, USA). Stationary phase 
cultures of the different E. coli strains were diluted 100-fold in prewarmed LB broth 
containing 50 g/ml spectinomycin. After incubating at 37ºC for 3 h in a shaker water bath at 
250 rpm, aliquots of 100 l (per triplicate) were taken from the cultures and centrifuged at 14 
000 rpm for 1 min. Pellets were resuspended in 100 l of 100 mM potassium phosphate, pH 
7.8, 2 mM EDTA, and cells lysed by freezing and thawing. Luciferase activity was 
determined using 5 l of the cell extract and 20 l of substrate (Promega Biotech Ibérica). 
Results are expressed as RLU per g of protein.  
 
2.9. Statistics 
 
Data are presented as mean ± s.e.m. Significance was determined using one-way 
analysis of variance (ANOVA) with a Bonferroni post-test or the Student’s t-test. All 
statistical analyses were performed using GraphPad Prism 4.0 software. 
 
3. Results 
 
3.1. Human podoplanin expressed in MDCK cells is associated with the detergent-insoluble 
membrane fraction  
 
When the insolubility of human podoplanin (expressed in MDCK cells as a fusion 
protein with eGFP) in cold non-ionic detergent was tested, we found that a substantial amount 
of podoplanin was insoluble at detergent concentrations of 0.2-0.5 % (Fig. 1A, B). Podoplanin 
was detected together with CD44 and Cav-1, two well established raft markers (Patra, 2008), 
in the low density DRM fraction isolated by flotation in OptiPrep
TM
 density gradients. 
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Treatment of the cells with methyl--cyclodextrin (CD) to sequester cholesterol before 
fractionation rendered most podoplanin, CD44 and Cav-1 soluble (at the bottom of the 
gradients), confirming the presence of these proteins in cholesterol-enriched DRMs (Fig. 1B). 
Furthermore, cell surface cholesterol depletion by CD treatment caused a redistribution of 
podoplanin and CD44 from microvilli to the entire cell surface (Fig. S1 in Supplementary 
material) as expected from the fact that cholesterol extraction from the plasma membrane 
reduces the number and length of microvilli (Poole et al., 2004). We found that podoplanin 
colocalizes at microvilli with the ganglioside GM1, but not with Cav-1 (data not shown), 
confirming the results of Barth and colleagues (2010). Since cholera toxin B-subunit (CTB)-
coated beads promote clustering of GM1-containing lipid rafts (del Pozo et al., 2004), we 
analyzed the effect of CTB-coated beads on podoplanin distribution at the cell surface. CTB-
mediated membrane clustering of GM1 led to the recruitment of both podoplanin and CD44. 
In contrast, beads coated with an antibody recognizing the transferrin receptor (TrfR), a non-
raft protein, were shown to have no effect on the distribution of PDPN (Fig. 1C).  
 
3.2. The TM domain of podoplanin is required for DRM association 
 
It has been shown that association with DRMs is an intrinsic characteristic of some 
proteins that is often determined by their TM domain (Scheiffele et al., 1997). Therefore, we 
examined the effect of replacing the TM domain of podoplanin with that of the adherens 
junction protein E-cadherin (ECD), the leukocyte common antigen CD45, or the Toll-like 
receptor TLR9 on its association with DRMs. Whereas ECD and CD45 are cell-surface 
proteins, TLR9 localizes at the endoplasmic reticulum and endosomes (Leifer et al., 2004). 
Wild-type podoplanin (PDPN-WT) and the chimeric constructs fused to eGFP (PDPN-ECD, 
PDPN-CD45, PDPN-TLR9) were stably expressed in MDCK cells and their sub cellular 
 11 
localization was analyzed by confocal microscopy (Fig. 2). In order to distinguish the proteins 
confined at the cell surface, the overall eGFP fluorescence signal was compared with the 
signal obtained after in vivo pre-embedding staining using a specific antibody recognizing the 
EC domain of podoplanin. PDPN-WT and PDPN-ECD were mainly directed to the cell 
surface, where they concentrated at membrane protrusions. Although some PDPN-CD45 had 
a perinuclear localization (likely at the Golgi apparatus), a substantial amount of this chimera 
also reached the plasma membrane but was distributed more homogeneously than PDPN-WT 
and PDPN-ECD. In contrast, most of PDPN-TLR9 was retained in the cytoplasm, 
accumulating at intracellular vesicles (Fig. 2, inset). We confirmed the cytoplasmic 
localization of PDPN-TLR9 by flow cytometry analysis (Fig. S2 in Supplementary material).  
Substitution of the TM domain of podoplanin led to decreased detergent insolubility 
(Fig. 3A) and exclusion from the DRM fractions isolated by OptiPrep
TM
 density gradients 
(Fig. 3B). Moreover, these mutants were not recruited by CTB-coated beads (Fig. S3 in 
Supplementary material). A similar effect was found for a podoplanin mutant that lacked the 
CT tail (PDPN-∆CT), while deletion of the EC domain (PDPN-∆EC) did not affect 
podoplanin association with the DRM fraction (Fig. 3A, B). These results suggest that both 
the TM and CT domains of podoplanin are important for its localization in lipid rafts. We also 
analyzed the detergent insolubility properties of a podoplanin isoform lacking two amino 
acids (YS) of the CT tail (PDPN-∆YS), which originates by alternative splicing and is 
normally expressed in human tissues (Martin-Villar et al., 2009). Most of PDPN-∆YS was 
found in the insoluble fraction (Fig. 3A) and its flotation on OptiPrep
TM
 density gradients was 
only slightly affected (Fig. 3B). 
 
3.3. The TM domain is required for podoplanin-mediated epithelial cell plasticity and 
migration 
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PDPN-WT expression in MDCK cells induced ROCK-dependent phosphorylation of 
ERM proteins and led to EMT associated with upregulation of N-cadherin and 
downregulation of E-cadherin expression. The capacity of PDPN-WT to induce an EMT in 
MDCK cells depends on the CT, but not the EC domain. Indeed, (Martín-Villar et al., 2006). 
Interestingly, podoplanin TM chimeric mutants, when expressed in MDCK cells at similar or 
higher levels than PDPN-WT, were unable to promote an EMT (Fig. 4A, B) or induce ERM 
phosphorylation (Fig. 4C, D). PDPN-WT-mediated ERM phosphorylation was inhibited by 
treatment of the cells with CD (Fig. 4E, F), suggesting that for podoplanin to activate ERM its 
association with cholesterol-enriched DRMs is required.  
PDPN-ECD, PDPN-CD45 and PDPN-TLR9 were also unable to stimulate MDCK cell 
migration, as shown in both Transwell and scratch assays (Fig. 5A, B). To further investigate 
the migratory behavior of MDCK cell transfectants, we tracked the migration pattern of a 
representative number of cells for each transfectant to study their random migration (Fig. 5C). 
PDPN-WT stimulated (~2 fold) the migration speed of MDCK cells (Fig. 5D): indeed control 
MDCK cells had an average speed of ~0.3 m/min while that of cells expressing PDPN-WT 
was ~0.6 m/min. Migration speeds for all MDCK cell chimeric transfectants were 
significantly reduced with respect to PDPN-WT expressing cells (Fig. 5D). In addition, we 
found that the movement of PDPN-WT- and PDPN-TLR9-MDCK cells were less random, 
more directional than that of cells expressing PDPN-ECD and PDPN-CD45 (Fig. 5E), and 
resulted in longer displacements for the former cell lines (Fig. 5F).  
 
3.4. The GXXXG motif within the TM domain is essential for podoplanin homodimerization, 
association with DRM, and EMT 
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In experiments aimed at detecting the expression of podoplanin in human tissues by 
Western blotting, we noticed the presence of a form of ~80 kDa in addition to the reported 
mature form of ~ 38 kDa (see several examples in Fig. 6B). The 80-kDa band most probably 
to a podoplanin non-covalent homodimer, since it disappeared together with the 38-kDa band 
following preincubation of the anti-podoplanin antibody with the immunogenic peptide (Fig. 
6B). Similar results have been found by Zimmer et al. (1999), both in MDCK type II cells 
expressing human podoplanin and MDCK type I cells expressing endogenous podoplanin. 
The TM domain of podoplanin is well conserved across species, particularly the region 
located at the N-terminus comprising a GXXXG motif (Fig. 6A and Table S2 in 
Supplementary material). GXXXG motifs have been involved in high affinity TM homomeric 
and heteromeric helix-helix associations (Russ and Engelman, 2000). Therefore, we analyzed 
podoplanin self-association by the TOXCAT assay that measures TM helix-helix association 
in the E. coli inner membrane (Russ and Engelman, 2000). As a positive control, we used a 
construct containing the M1 TM segment of ENAC (Kashlan et al., 2006). Bacteria 
harbouring PDPN-WT or ENAC were able to grow in chloramphenicol, in contrast to bacteria 
harbouring the empty vector (data not shown). These results were confirmed (Fig. 6C) in a 
second set of experiments by directly measuring luciferase activity with a modified version of 
pML27 in which CAT was replaced with luciferase (see Supplementary material). In these 
assays, we included a podoplanin construct with the TM GXXXG motif mutated to GXXXL 
(PDPN-G137L). In contrast to PDPN-WT, PDPN-G137L was unable to self-associate (Fig. 
6C), indicating that the TM GXXXG motif is necessary for dimerization.  
In order to ascertain whether this mutant protein was associated with DRM, we 
expressed PDPN-G137L as a fusion protein with eGFP in MDCK cells. As shown in Fig. 6D, 
PDPN-G137L did not float on an OptiPrep
TM
 density gradient, indicating that the G137L 
mutation blocks podoplanin association with the DRM fraction. Furthermore, this construct 
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was not recruited by CTB-coated beads (Fig. 3S). We next analyzed whether PDPN-G137L 
conserved the ability to promote an EMT. All analyzed clones transfected with PDPN-G137L 
exhibited an epithelial morphology. Expression of PDPN-G137L in these clones was rather 
heterogeneous, ranging from very low levels in some cells to high levels in others. However, 
even cells synthesizing high levels of PDPN-G137L had a polygonal morphology and 
preserved the expression of E-cadherin at cell-cell contacts. In addition, cells expressing 
PDPN-G137L had strong cortical F-actin bundles and short thin stress fibers, whereas cells 
expressing PDPN-WT exhibited weaker cortical F-actin and longer and thicker stress fibers 
typical of fibroblasts (Fig. 7A). Furthermore, the G137L mutation hampered podoplanin-
mediated ERM phosphorylation, as shown by confocal immunofluorescence microscopy (Fig. 
7B). These results suggest that mutation of the TM GXXXG motif impairs podoplanin self 
association, prevents its localization at cholesterol-rich membrane micro domains, and blocks 
podoplanin-mediated EMT. 
 
4. Discussion  
 
Lipid rafts platforms are specialized plasma membrane micro domains rich in 
cholesterol, sphingolipids and proteins (Simons and Toomre, 2000). Recent findings indicate 
that these structures are dynamic and heterogeneous, although some proteins are clearly 
“raftophylic” (Brown, 2006), like Cav-1 or prominin-1, (Roper et al., 2000). In this work, we 
show that human podoplanin expressed in MDCK cells associates with these structures, in 
accordance with its microvillar plasma membrane location (Scholl et al., 1999; Martin-Villar 
et al., 2005). 
We have investigated the structural basis for podoplanin raft association by examining 
the detergent insolubility of several mutant constructs affecting its EC, TM and CT domains. 
 15 
All mutant proteins, except for PDPN-∆EC, lost the detergent-resistant properties exhibited 
by wild type podoplanin, indicating that both the TM and CT domains are required for 
podoplanin localization in lipid rafts. We had previously proposed a model in which the 
interaction of podoplanin with ezrin/moesin induced the activation of RhoA/ROCK, thus 
leading to further activation of ERM proteins and the induction of an EMT (Martín-Villar et 
al., 2006). We show in this work that disruption of lipid rafts by CD impairs podoplanin-
mediated ERM phosphorylation. In addition, none of the podoplanin mutant proteins unable 
to include into rafts stimulated ERM phosphorylation, EMT or cell migration in MDCK cells. 
These results suggest that activation of ERM proteins and promotion of EMT by podoplanin 
requires its association with raft membrane micro domains. It has been shown that resistance 
to detergent extraction may vary depending on the cell type (Neame and Isacke, 1993); thus 
raising the possibility that the inability of podoplanin chimeras and the CT mutant to 
associate with DRMs is due to the fact that these proteins retain the epithelial phenotype, 
whereas PDPN-WT and PDPN-EC have a fibroblastic one. However, this argument can be 
ruled out as PDPN-YS, a shorter podoplanin isoform (Martin-Villar et al., 2009) while 
unable to promote an EMT or activate ERM proteins in MDCK cells (M.M. Yurrita, J. Renart 
and M. Quintanilla, manuscript in preparation) is associated with the DRM fraction. This fact 
appears to indicate that DRM association is necessary but not sufficient for podopanin’s effect 
on epithelial plasticity. 
The requirement of the TM domain for podoplanin localization in cholesterol-rich 
membrane micro domains is probably due to direct protein-lipid interactions mediated by 
hydrophobic residues located mostly in the exoplasmic half of this domain as has been 
described for other proteins (Scheiffele et al., 1997). Several hypothesis can be proposed to 
explain the dependence of podoplanin raft localization on its CT domain. For instance, it has 
been shown that peptides with both basic and aromatic amino acid residues bind to 
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membranes (Arbuzova et al., 2000), and the podoplanin CT has this structure. On the other 
hand, we have previously described the anchorage of podoplanin to the actin cytoskeleton via 
its association with ezrin/moesin (Scholl et al., 1999; Martín-Villar et al., 2006), and ezrin is a 
predominantly raft protein (Gupta et al., 2006).Recent reports indicate that membrane rafts 
dynamics is controlled by proteins that are linked to the actin cytoskeleton (Viola and Gupta, 
2007). Therefore, recruitment of podoplanin into lipid rafts could be necessary for its proper 
binding to ezrin and the actin cytoskeleton. Moreover, as has been described for CD44, and 
ERM-binding protein whose association with the actin cytoskeleton is regulated by lipid raft 
inclusion (Oliferenko et al., 1999), podoplanin inclusion into rafts could be important for the 
activation of the RhoA/ROCK pathway. In this regard, we have recently reported that 
podoplanin interacts with CD44 at plasma membrane protrusions (Martin-Villar et al., 2010). 
The analysis of cell tracks during random migration revealed that PDPN-WT 
increased both the speed and directionality of MDCK cells. We also observe that PDPN-
TLR9, which accumulated at intracellular vesicles, promoted a more directional movement 
while barely stimulating the speed of migration. The molecular bases for those observations 
are presently unknown. However, the fact that both PDPN-WT and PDPN-TLR9 were able to 
promote directionality during cell migration suggests that this function might involve 
podoplanin endocytosis or turnover from the cell surface. The subcellular distribution of 
PDPN-TLR9 corresponds to that of wild type TLR9 (Leifer et al., 2004). This result suggests 
that the TM domain of TLR9 is essential for its correct subcellular localization, which is in 
accordance with Kajita et al. (2006). However, other reports suggest that it is the CT domain 
and not the TM domain that controls the internal localization of TLR9 (Leifer et al., 2006). In 
this respect, it is worth mentioning that the opposite chimera, in which the TM domain of 
TLR9 was substituted by the TM region of podoplanin, is not directed to the cell surface but 
retained in the endoplasmic reticulum (data not shown), suggesting that neither the TM 
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domain of podoplanin nor that of TLR9 by themselves are sufficient for the subcellular 
distribution of the corresponding proteins. 
The TM GXXXG motif appears to play an essential role in podoplanin’s function and 
association with lipid rafts. The GXXXG motif has been established as a framework for the 
helix-helix interaction of TM domains and has been shown to mediate both homomeric and 
heteromeric association of TM helices (Gerber et al., 2004). Using a TOXLUC reporter 
system we indeed demonstrate that the TM GXXXG motif mediates podoplanin self-
assembly in a membrane microenvironment. The GXXXG motif appears to be essential for 
podoplanin function since the PDPN-G137L mutant was unable to induce EMT or promote 
ERM phosphorylation. Altogether, these results suggest that TM mediated lateral clustering is 
important for retention of podoplanin in cholesterol-based membrane lipid rafts, which in turn 
may regulate podoplanin interaction with the actin cytoskeleton and podoplanin function. 
Currently, lipid rafts are viewed as dynamic nanoscale assemblies of sphingolipids, 
cholesterol and proteins that can coalesce by TM protein oligomerization into larger raft 
platforms stabilized by scaffolding elements, such as cortical actin (Lingwood and Simons, 
2010). These platforms function in membrane signalling and may be required for specific 
events, such as EMT. Indeed, it has been recently reported that TGF--induced EMT is 
dependent on cholesterol-rich lipid rafts (Zuo and Chen, 2009). We provide in this work 
further evidence for the involvement of lipid rafts in EMT induction. 
In summary, our results support that podoplanin is a raftophylic protein. Indeed, 
podoplanin is found in DRMs, and treatment with CD reduces its presence in these fractions. 
In addition, we have previously shown that podoplanin interacts with other raft proteins, like 
CD44 and ERMs, that also interact with the actin cytoskeleton. Both podoplanin and CD44 
are able to signal via the RhoA/ROCK pathway. We observed a perfect correlation between 
the presence in DRMs and the ability to phosphorylate ezrin for all the podoplanin mutant and 
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chimeric proteins that we have studied. Furthermore this correlation is independent of the 
phenotype of the cells studied. Finally, we provide evidence for the involvement of the TM 
domain of podoplanin in its homodimerization via its GXXXG domain. This process, together 
with the interactions mentioned above, could enhance the formation of raft platforms and raft 
phases, likely involved in cell movement, in which podoplanin is clearly involved. 
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Figure captions 
 
Fig. 1. Podoplanin is associated with the detergent-resistant cholesterol-rich membrane 
fraction. (A) MDCK cells expressing wild type PDPN fused to eGFP were lysed at 4ºC in 
0.2% Triton X-100 and the levels of podoplanin in the soluble (S) and insoluble (I) fractions 
were determined by Western blotting. -tubulin and cytokeratin 8 (CK8) were used as 
controls for soluble and insoluble proteins, respectively.  (B) MDCK cells expressing wild-
type PDPN fused to eGFP were treated with CD or vehicle and lysed at 4ºC in 0.5% Triton X-
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100. Cell lysates were subjected to flotation on OptiPrep
TM
 density gradients, and the 
expression levels of PDPN, CD44 and caveolin-1 (Cav-1) in the gradient fractions determined 
by Western blotting. Fractions 1-8 represent low (0%) to high (35% Optiprep) density. TL, 
total lysate. (C) Recruitment of both PDPN and CD44 by CTB-coated beads. MDCK-PDPN-
eGFP cells plated on coverslips were incubated with 5-m polystyrene beads coated with 
CTB or -TrfR (negative control) for 15 min. Cells were then processed for 
immunofluorescence to detect CD44.  
 
Fig. 2. Subcellular localization of PDPN wild-type and mutant proteins. Confocal images of 
horizontal sections of MDCK cells expressing the indicated PDPN constructs fused to eGFP 
are shown. Protein specifically expressed at the cell surface was detected by in vivo 
preembedding staining using an antibody recognizing the EC domain of PDPN. Inset in 
PDPN-TLR9 indicates localization of the mutant protein at internal vesicles (arrow). Bars, 25 
m.  
 
Fig. 3. Detergent insolubility properties of podoplanin mutant proteins. MDCK cells 
expressing wild-type and the indicated mutant PDPN proteins fused to eGFP were lysed at 
4ºC in either 0.2% (A) or 0.5% (B) Triton X-100 and processed as indicated in the legend of 
Fig. 1. In panel A, the ratio of insoluble to soluble fraction loaded onto the gel was 4:1 in 
order to better visualize changes in Triton X-100 insolubility of mutant proteins with respect 
to wild type PDPN. In panel B, fractions 1-8 represent low (0%) to high (35% Optiprep) 
density.   
 
Fig. 4. The TM domain is important for podoplanin-induced EMT. (A) Phase contrast 
micrographs of MDCK cells expressing the indicated constructs. (B) Western blot analysis of 
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PDPN proteins and of the differentiation-related markers E-cadherin (E-CD) and N-cadherin 
(N-CD) in MDCK cells transfected with the indicated constructs or the empty vector (eGFP). 
Two different clones per each PDPN chimeric mutant are shown. -tubulin was a used as a 
control for protein loading. (C) Representative western blot analysis of phospho-ERM and 
total ezrin levels in the indicated MDCK cell transfectants. (D) Quantification of ERM protein 
activation, expressed as P-ERM over total ezrin levels, in TM chimeras (n=6). (E) 
Representative western blot analysis of phospho-ERM and total ezrin levels in MDCK cells 
transfected with the empty vector (eGFP) and wild type PDPN before and after treatment with 
CD. (F) Quantification of ERM protein activation relative to control cells after treatment with 
CD, expressed as ERM activation over ERM activation in MDCK-eGFP cells (n=3). P-values 
(panels D and F) were obtained using a one-way analysis of variance (ANOVA) with a 
Bonferroni post-test and the Student’s t-test respectively: *p<0.05; **p<0.01; ***p<0.001. 
Fig. 5. Substitution of the TM domain of podoplanin impairs cell migration. (A) Transwell 
migration assay of MDCK cells transfected with the indicated constructs. (B) Wound healing 
assay. MDCK cells expressing PDPN-WT closed completely a wound made 12 h before 
while control cells (eGFP) and cells expressing PDPN mutant proteins did not. (C-F) Random 
cell migration assay. The traces of the movement of a representative number of cells (n = 20) 
during a 15 h period for the indicated transfectants are represented as wind-rose plots (C). For 
mean migration speed (D), directionality (E) and displacement (F) determinations, the number 
of cells tracked was as follow: eGFP), n = 65; PDPN-WT, n = 42; PDPN-ECD, n = 63; 
PDPN-CD45, n = 25; PDPN-TLR, n = 92. Bar graphs (mean + s.e.m.) are representative of 
three independent experiments. P-values were obtained using the Student’s t-test. **p<0.01; 
***p<0.001. 
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Fig. 6. A GXXXG motif within the TM region is involved in podoplanin homodimerization 
and association with the DRM fraction. (A) Sequence Logo (Crooks et al., 2004) generated 
from the alignment of the TM domain of podoplanin from the different species shown in 
Table S2. The human TM sequence of podoplanin (with the GXXXG motif underlined) is 
presented below. (B) Western blot analysis of podoplanin expressed in human normal and 
tumor tissues using an antibody preincubated or not with the immunogenic peptide (P37-51) 
to detect podoplanin specific forms. CRC, colorectal carcinoma. (C) TOXLUC assay to 
measure homodimerization of the indicated TM domains at the inner membrane of E. coli. 
ENAC was used as a positive control. Note that mutation of the last G in the GXXXG motif 
(G137L) inhibits podoplanin homodimerization. Results are the mean of three independent 
biological experiments carried out in triplicate. P-values were obtained using a one-way 
analysis of variance (ANOVA) with a Bonferroni post-test. *p<0.05; **p<0.01. (D) The 
G137L mutation blocks PDPN association with the DRM fraction. The lysates of MDCK 
cells expressing either the PDPN-WT or PDPN-G137L mutant proteins obtained as described 
in the legend of Figure 1B were subjected to flotation on OptiPrep
TM
 density gradient, and the 
expression of PDPN and Cav-1 determined in the gradient fractions by Western blotting.  
 
Fig. 7. Mutation of the TM GXXXG motif prevents podoplanin-mediated ERM 
phosphorylation and EMT. Confocal fluorescence detection of E-cadherin and F-actin (A) and 
of phospho-ERM proteins (B) in MDCK cells expressing PDPN-WT and mutant PDPN-
G137L fused to eGFP. Cells were labelled with specific antibodies against E-cadherin (E-CD) 
and phosphor-ERM or with Alexa Fluor coupled to phalloidin. Nuclei were stained with 
DAPI. In panel B, laser intensity and gain were adjusted for PDPN-WT and maintained for 
PDPN-G137L. 
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